Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

JSE/LAB stock hub

JSE/LAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

JSE/LABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

37.5M

Johannesburg Stock Exchange

Market data

Price

Recent price action with selectable time range.

JSE/LABJSE/LAB

—

Loading chart…

In the news

Latest news · JSE/LAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E0.3

P25 n/aP50 n/aP75 n/a

ROE128

P25 n/aP50 n/aP75 n/a

ROIC43.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All JSE/LAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

ZAR

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Africa
Country code	ZA
Employees	43
Employees Change	-5%
Employees Change Percent	-10.42
Enterprise value	ZAc 179.8M
Exchange	Johannesburg Stock Exchange
Financial currency	ZAR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ZAE000018354
Last refreshed	2026-05-10
Market cap	ZAc 37.5M
Price	ZAc 3
Price currency	ZAc
Rev Per Employee	7,371,441.86x
Sector	Healthcare
Sic	3674
Symbol	jse/LAB
Website	https://www.labat.co.za

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	413.08%
EV Earnings	1.16x
EV/EBIT	1.17x
EV/EBITDA	1.14x
EV/FCF	6.74x
EV/Sales	0.57x
FCF yield	71.15%
P/B ratio	0.12x
P/E ratio	0.28x
P/S ratio	0.12x
PE Ratio3 Y	0.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	48.34%
EBITDA Margin	49.55%
FCF margin	8.41%
Gross margin	61.51%
Gross Profit	ZAc 195M
Gross Profit Growth	65.82%
Gross Profit Growth Q	346.41%
Gross Profit Growth3 Y	87.79%
Gross Profit Growth5 Y	75.21%
Net Income	ZAc 154.8M
Net Income Growth Q	483.83%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Pretax Margin	65.24%
Profit Margin	48.83%
Profit Per Employee	ZAc 3.6M
Profitable Years	1
ROA	21.18
ROCE	44.64
ROE	128
ROIC	43.17
Roic5y	-114.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-23.2%
Cagr15y	-14.23%
Cagr1y	-50.02%
Cagr20y	-6.29%
Cagr3y	-30.66%
Cagr5y	-34.56%
EPS Growth Q	203.7
EPS Growth Quarters	3
EPS Growth Years	2
FCF Growth	324.44%
FCF Growth Q	1,730.09%
FCF Growth3 Y	108.5%
OCF Growth	329.9%
OCF Growth Q	1,697.84%
OCF Growth10 Y	4.25%
OCF Growth3 Y	108.87%
Revenue Growth	601.56x
Revenue Growth Q	352.94x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	86.92x
Revenue Growth5 Y	59.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ZAc 0.7
Assets	ZAc 769.8M
Cash	ZAc 932,000
Current Assets	ZAc 718.5M
Current Liabilities	ZAc 426.6M
Debt	ZAc 19.8M
Debt EBITDA	ZAc 0.13
Debt Equity	ZAc 0.06
Debt FCF	ZAc 0.74
Equity	ZAc 313.8M
Interest Coverage	78.74
Liabilities	ZAc 456M
Long Term Assets	ZAc 51.4M
Long Term Liabilities	ZAc 29.5M
Net Cash	ZAc -18.9M
Net Cash By Market Cap	ZAc -50.48
Net Debt EBITDA	ZAc 0.12
Net Debt Equity	ZAc 0.06
Net Debt FCF	ZAc 0.71
Tangible Book Value	ZAc 190.4M
Tangible Book Value Per Share	ZAc 0.15
WACC	8.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.68
Inventory Turnover	0.67
Net Working Capital	ZAc 301.7M
Quick ratio	0.83
Working Capital	ZAc 291.9M
Working Capital Turnover	ZAc 2.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-115.27%
Dividend per share	ZAc 0
Last Dividend	ZAc 0.02

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-92.86%
1Y total return	-50%
200-day SMA	5.53
3Y total return	-66.67%
50-day SMA	4.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-88%
All Time High	180
All Time High Change	-98.33%
All Time High Date	1999-06-15
All Time Low	1
All Time Low Change	200%
All Time Low Date	2009-02-06
ATR	0.6
Beta	0.65
Beta1y	0.41
Beta2y	0.02
Ch YTD	-62.5
High	3
High52	14
High52 Date	2025-10-16
High52ch	-78.57%
Low	3
Low52	2
Low52 Date	2026-05-07
Low52ch	50%
Ma50ch	-34.78%
Price vs 200-day SMA	-45.75%
RSI	30.62
RSI Monthly	35.32
RSI Weekly	39.53
Sharpe ratio	0.67x
Sortino ratio	1.12
Total Return	-115.27%
Tr YTD	-62.5
Tr15y	-90%
Tr1m	-25%
Tr3m	-50%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ZAc 153.2M
Operating Income Growth	139.9
Operating Income Growth Q	1,047.5
Operating margin	48.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,100,238,530%
Net Borrowing	-28,499,000
Shares Insiders	3.49%
Shares Out	1,248,875,595
Shares Qo Q	-20.77%
Shares Yo Y	115.27%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ZAc 26.7M
Average Volume	18,774,643.1x
Bv Per Share	0.15
CAPEX	ZAc -605,000
Ch10y	-92.86
Ch15y	-90
Ch1m	-25
Ch1y	-50
Ch20y	-72.73
Ch3m	-50
Ch3y	-66.67
Ch5y	-88
Ch6m	-50
Change	0%
Change From Open	0
Close	3
Days Gap	0
Depreciation Amortization	3,832,000
Dollar Volume	12,680,652
Earnings Date	2026-05-12
EBIT	ZAc 153.2M
EBITDA	ZAc 157.1M
EPS	ZAc 0.11
F Score	5
FCF	ZAc 26.7M
FCF EV Yield	14.83x
FCF Per Share	ZAc 0.02
Financing CF	-28,499,000
Fiscal Year End	May
Founded	1,986
Graham Number	0.60911
Graham Upside	-79.7
Income Tax	ZAc 12.9M
Investing CF	-5,610,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-11-30
Last Split Date	1999-06-14
Last Split Type	Forward
Ma150	5.57
Ma150ch	-46.11%
Ma20	4.1
Ma20ch	-26.83%
Net CF	-6,844,000
Next Earnings Date	2026-05-12
Open	3
P FCF Ratio	1.41
P OCF Ratio	1.37
Ppne	8,885,000
Price Date	2026-05-08
Price EBITDA	ZAc 0.24
Ptbv Ratio	0.2
Relative Volume	0.23x
Revenue	316,972,000x
Tax By Revenue	4.08x
Tax Rate	6.26%
Tr20y	-72.73%
Tr6m	-50%
Volume	4,226,884
Z Score	1.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does JSE/LAB pay a dividend?

Capital-return profile for this ticker.

Performance

JSE/LAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns JSE/LAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+3.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+115.3%

Negative means the company is buying back shares.

Technical

JSE/LAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

30.6

Neutral momentum band

Price vs 200-day MA

-45.8%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

0.67

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About JSE/LAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current jse/LAB stock rating?

jse/LAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full jse/LAB analysis?

The full report lives at /stocks/jse/LAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for jse/LAB?

The latest report frames jse/LAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the jse/LAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.